[The administration of sandostatin in the combined treatment of acute pancreatitis and its complications].
Experience of application of the somatostatin synthetic analog sandostatin ("Novartis" firm) in treatment of 212 patients, including 84--with an acute pancreatitis (AP), 41--with postoperative AP (APP), 15--with external pancreatic fistula and 72--with high risk of the APP occurrence for prophylaxis was summarized. The significant inhibiting action of preparation on endocrine pancreatic function was noted. High efficacy of sandostatin in patients with AP and its complications was determined.
Saenko
V F
VF
Lupal'tsov
V I
VI
Babenkov
G F
GF
Kopchak
V M
VM
Volzhanskiĭ
A P
AP
D000208:Acute Disease; D003131:Combined Modality Therapy; D005260:Female; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D015282:Octreotide / Q000627:therapeutic use*; D010185:Pancreatic Fistula / Q000188:drug therapy* / Q000209:etiology* / Q000601:surgery; D010195:Pancreatitis / Q000150:complications* / Q000188:drug therapy* / Q000601:surgery
D005765:Gastrointestinal Agents; D015282:Octreotide
Primenenie sandostatina v komplekse lecheniia ostrogo pankreatita i iego oslozhneniĭ.